LifeMD, Inc.
LifeMD, Inc.
- Market cap
- $131.19M
Your view on LFMDP
Overview
What the company does, where it operates, and who runs it.
About LifeMD, Inc.
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Justin Schreiber
- Headquarters
- 236 Fifth Avenue, New York City, NY, US
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Justin Schreiber
- Headquarters
- 236 Fifth Avenue, New York City, NY, US
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States.
The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .
offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers.
It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels.
The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for LifeMD, Inc.. Starting points for LifeMD, Inc.: EPS -$0.46, beta 2.06 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for LifeMD, Inc.. LifeMD, Inc. paid $2.22 per share over the last year — a 11.5% yield at the current $19.24 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for LifeMD, Inc.. Trailing twelve-month EPS for LifeMD, Inc. stands at -$0.46. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Buy
Analyst ratings
3 ratings- Strong Buy0
- Buy3
- Hold0
- Sell0
- Strong Sell0
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | −$0.16 | −$0.09 | −$0.61 | −$0.35 |
| Lowest estimate | −$0.18 | −$0.11 | −$0.66 | −$0.38 |
| Highest estimate | −$0.15 | −$0.09 | −$0.56 | −$0.33 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | $0.411 | −$0.20 | −$0.231 | — |
| Growth vs a year ago | — | +52.9% | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | $47.05M | $53.95M | $189.18M | $232.85M |
| Lowest estimate | $45.98M | $51.01M | $188.04M | $207.93M |
| Highest estimate | $48.78M | $62.42M | $190.87M | $255.08M |
| Number of analysts | 8 | 7 | 8 | 8 |
| A year ago | $46.87M | $50.16M | $194.06M | — |
| Growth vs a year ago | +0.4% | +7.6% | −2.5% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for LifeMD, Inc.. LifeMD, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| ATAIAtai Life Sciences N.V. | Healthcare | Biotechnology | $2.7B | ||
| CTEVClaritev Corporation | Healthcare | Medical - Healthcare Information Services | $380.8M | ||
| DNTHDianthus Therapeutics, Inc. | Healthcare | Biotechnology | $4.7B | ||
| ELVNEnliven Therapeutics, Inc. | Healthcare | Biotechnology | $3.3B | ||
| INBXInhibrx Biosciences, Inc. | Healthcare | Biotechnology | $1.0B | ||
| NKTRNektar Therapeutics | Healthcare | Biotechnology | $987.4M | ||
| OPKOPKO Health, Inc. | Healthcare | Medical - Diagnostics & Research | $1.3B | ||
| PGENPrecigen, Inc. | Healthcare | Biotechnology | $1.5B | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| ICR.AXIntelicare Holdings Limited | Healthcare | ASX | — | ||
| IGRWInteractive Health Network | Healthcare | OTC | $39,815 | ||
| LFCOFLift & Co. Corp. | Healthcare | OTC | $71,601 | ||
| LFMDLifeMD, Inc. | Healthcare | NASDAQ | $82.2M | ||
| LVCELiveCare, Inc. | Healthcare | OTC | $381,860 | ||
| LYNX.CNLynx Global Digital Finance Corporation | Healthcare | CNQ | $6.4M | ||
| M7T.AXMach7 Technologies Limited | Healthcare | ASX | — | ||
| MDBIFTrivarX Limited | Healthcare | OTC | $1.6M | ||
| MDNWFMednow Inc. | Healthcare | OTC | $517,288 | ||
| MDRXVeradigm Inc. | Healthcare | OTC | $730.3M | ||
| MDXLMediXall Group, Inc. | Healthcare | OTC | $20,551 | ||
| MGRXMangoceuticals, Inc. | Healthcare | NASDAQ | $3.3M | ||
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by LifeMD, Inc. executives and directors. Shares of LifeMD, Inc. have traded between $21.14 and $27.44 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for LifeMD, Inc.. Coverage tracks LifeMD, Inc. within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of LifeMD, Inc.